General Information of the Compound
Compound ID
CP0515620
Compound Name
4-Benzyl-1H-imidazole derivative, 21
    Show/Hide
Synonyms
4-(3-Pent-1-ynyl-benzyl)-1H-imidazole
4-Benzyl-1H-imidazole derivative, 21
BDBM22540
CHEMBL451399
    Show/Hide
Structure
Formula
C15H16N2
Molecular Weight
224.307
Canonical SMILES
CCCC#Cc1cccc(Cc2cnc[nH]2)c1
    Show/Hide
InChI
InChI=1S/C15H16N2/c1-2-3-4-6-13-7-5-8-14(9-13)10-15-11-16-12-17-15/h5,7-9,11-12H,2-3,10H2,1H3,(H,16,17)
    Show/Hide
InChIKey
JAPGJDHRYBFKBD-UHFFFAOYSA-N
Physicochemical Property
logP
3.1521
Rotatable Bonds
3
Heavy Atom Count
17
Polar Areas
28.68
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
1
Complexity
17

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 24825518
SID: 50096918
ChEMBL ID
CHEMBL451399
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01194, Histamine H3 receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000011 CHO Cricetulus griseus (Chinese hamster)  1
1
Ki = 3.162 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( 4-(3-Pent-1-ynyl-benzyl)-1H-imidazole )
Drug Name 4-(3-Pent-1-ynyl-benzyl)-1H-imidazole
Target(s)
Debrisoquine 4-hydroxylase (CYP2D6)
Inhibitor